Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hereditary hemochromatosis (HH) is a common genetic disease leading to accumulation of iron in several organs, most notably the liver. The C282Y/C282Y mutation in the HFE gene is found in most cases. In order to prevent clinical disease and to study the cost and feasibility of screening, a large population was screened. METHODS: In a Norwegian county, all inhabitants 20 years or older were invited to participate in a population-based health survey programme. Screening for HH was one of several subprojects. Blood samples were obtained from 65,238 persons. Subjects with high serum transferrin saturation in two tests and high serum ferritin were clinically evaluated for HH. All subjects with high serum transferrin saturation in two tests were offered genotyping. RESULTS: HH was newly diagnosed in 92 women and 177 men. Phlebotomy treatment was performed in 64 women and 152 men. Severe organ damage (liver cirrhosis) was ascertained in only 4 men. We found no correlation between serum ferritin and age. The estimated cost was US$ 1.6 per subject screened and US$ 390 per newly discovered HH subject. The estimated prevalence of phenotypical HH not previously known was 0.34% in women and 0.68% in men. The prevalence of the C282Y/C282Y mutation was at least 0.68%. CONCLUSION: Large-scale screening for HH can be performed at a relatively low cost if combined with a health survey programme. The yield in terms of newly discovered cases is considerable, but few cases were found seriously ill. Better knowledge of the natural course of HH is necessary if we are to be able to estimate the cost-effectiveness of large-scale screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 1×
“A candidate gene for HH (the HFE gene) was discovered in 1996 (4).”
BackgroundAn Introduction to Medical Statistics.
(1931) · Journal of the American Medical Association · doi:10.1001/jama.1931.02730150055037 · Cited by 2,084
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D., & Strohmeyer, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 890
Global prevalence of putative haemochromatosis mutations.
Merryweather-Clarke, A. T., Pointon, J. J., Shearman, J. D., & Robson, K. J. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 789
A Population-Based Study of the Clinical Expression of the Hemochromatosis Gene
Olynyk, J. K., Cullen, D. J., Aquilia, S., Rossi, E., Summerville, L., & Powell, L. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411002 · Cited by 702
Bassett, M. L., Halliday, J. W., & Powell, L. W. (1986) · Hepatology · doi:10.1002/hep.1840060106 · Cited by 664
MacSween, N. M. R. (1979) · Churchill Livingstone eBooks · Cited by 575
Witte, D. L., Crosby, W. H., Edwards, C. Q., Fairbanks, V. F., & Mitros, F. A. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06212-2 · Cited by 321
Molecular medicine and hemochromatosis: At the crossroads
Bacon, B. R., Powell, L. W., Adams, P. C., Kresina, T. F., & Hoofnagle, J. H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70244-1 · Cited by 286
EASL International Consensus Conference on Haemochromatosis
Adams, P., Brissot, P., & Powell, L. W. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(01)80874-6 · Cited by 284
Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening
Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., Barton, J. C., Beutler, E., Brittenham, G., Buchanan, A., et al. (1998) · JAMA · doi:10.1001/jama.280.2.172 · Cited by 276
Desforges, J. F., Edwards, C. Q., & Kushner, J. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282208 · Cited by 247
Adams, P. C., Deugnier, Y., Moirand, R., & Brissot, P. (1997) · Hepatology · doi:10.1002/hep.510250130 · Cited by 241
Jeffrey, G. P., Chakrabarti, S., Hegele, R. A., & Adams, P. C. (1999) · Nature Genetics · doi:10.1038/11892 · Cited by 165
Emery's elements of medical genetics
Turnpenny, P. D., & Ellard, S. (1998) · Cited by 165
Adams, P. C., Gregor, J. C., Kertesz, A. E., & VALBERG, L. S. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90283-x · Cited by 146
Haemochromatosis in the new millenium
Powell, L. W., Subramaniam, V. N., & Yapp, T. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80415-8 · Cited by 131
Adams, P. C., Kertesz, A. E., McLaren, C. E., Barr, R., Bamford, A., & Chakrabarti, S. (2000) · Hepatology · doi:10.1053/he.2000.6984 · Cited by 120
Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients
Phatak, P. D., Sham, R. L., Raubertas, R. F., Dunnigan, K., O'Leary, M. T., Braggins, C., & Cappuccio, J. D. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00006 · Cited by 112
Cost-effectiveness of Screening for Hereditary Hemochromatosis
Phatak, P. D., Guzman, G., Woll, J. E., Robeson, A., & Phelps, C. E. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.7.769 · Cited by 110
Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening
Cogswell, M. E., McDonnell, S. M., Khoury, M. J., Franks, A. L., Burke, W., & Brittenham, G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00008 · Cited by 108
Erf, L. A., & Stasney, J. (1956) · PubMed · Cited by 105
HFE mutations in patients with hereditary haemochromatosis in Sweden
Cardoso, Stål, Hagen, Cabeda, Cabeda, Esin, Sousa, D., & Hultcrantz (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00270.x · Cited by 104
Niederau, C., Niederau, C. M., Lange, S., Littauer, A., Abdel-Jalil, N., Maurer, M., Haussinger, D., & Strohmeyer, G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-5-199803010-00001 · Cited by 94
Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older
Baer, D. M., Simons, J. L., Staples, R. L., Rumore, G. J., & Morton, C. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80346-5 · Cited by 93
Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients
Balan, V., Baldus, W. P., Fairbanks, V. F., Michels, V. V., Burritt, M. F., & Klee, G. G. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90171-6 · Cited by 92
McDonnell, S. M., Hover, A. R., Gloe, D. S., Ou, C., Cogswell, M. E., & Grummer‐Strawn, L. M. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00163-1 · Cited by 84
Epidemiology, Clinical Spectrum and Prognosis of Hemochromatosis
Niederau, C., Strohmeyer, G. W., & Stremmel, W. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_31 · Cited by 78
Distante, S., Berg, J. P., & Lande, K. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750026290 · Cited by 75
Distante, S., Berg, J. P., Lande, K., Haug, E., & Bell, H. (2000) · Gut · doi:10.1136/gut.47.4.575 · Cited by 55
Screening for haemochromatosis: prevalence among Danish blood donors
Wiggers, P., Dalhøj, J., Kiær, H., Ring‐Larsen, H., Petersen, P. H., Blaabjerg, O., & Hørder, M. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00441.x · Cited by 52
Prevalence of hereditary haemochromatosis in two Swedish urban areas
Hallberg, L., Björn‐Rasmussen, E., & Jungner, I. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb00074.x · Cited by 50
7 Clinical spectrum and management of haemochromatosis
Niederau, C., Stremmel, W., & Strohmeyer, G. W. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80129-5 · Cited by 47
Prevalence of Hemochromatosis in Finland
KARLSSON, M., Ikkala, E., Reunanen, A., Takkunen, H., Vuori, E., & Mäkinen, J. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb19599.x · Cited by 40
Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis
Buffone, G. J., & Beck, J. R. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.8.1631 · Cited by 40
Preventing Manifestations of Hereditary Haemochromatosis through Population Based Screening
Haddow, J. E., & Ledue, T. B. (1994) · Journal of Medical Screening · doi:10.1177/096914139400100106 · Cited by 19
Cited by
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., Dawkins, F. W., Acton, R. T., Harris, E. L., Gordeuk, V. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041534 · Cited by 775
Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011) · Hepatology · doi:10.1002/hep.24330 · Cited by 723
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
Eid, R., Arab, N. T. T., & Greenwood, M. T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 288
Metadata
- Authors
- A. Åsberg, K. H.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 36
- Issue
- 10
- Pages
- 1108-1115
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2097405210
- Cited by
- 296
- References
- 37
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.